Skip to main content
. Author manuscript; available in PMC: 2024 Aug 1.
Published in final edited form as: Head Neck. 2023 May 19;45(8):1903–1912. doi: 10.1002/hed.27402

Table 4.

Odds ratios for major postoperative outcomes by NLR group after sensitivity analyses

Outcome Prevalence, % Odds Ratio 95% CI
With Cancer Data, N = 6,588
 Death within 30 days 1.0 2.15* 1.27–3.64
 1 or more VASQIP complications 14.5 1.29* 1.09–1.53
No Chemotherapy, N = 11,003
 Death within 30 days 1.0 2.09* 1.39–3.13
 1 or more VASQIP complications 13.2 1.38* 1.21–1.57

Abbreviations: NLR, neutrophil-to-lymphocyte ratio; CI, confidence interval